This classifier comprises 82 CNS tumor methylation classes and uses the information on methylation status (e.g., IDH status) as well as copy number changes (e.g., 1p19q co-deletion) to classify the tumors. The gene discussed is IDH2; the disease is central nervous system neoplasm.